World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02299908
Date of registration: 17/11/2014
Prospective Registration: No
Primary sponsor: Patricia Salazar Villegas
Public title: Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial
Scientific title: Ultrasound-guided Transverses Abdominis Plane Block in Inguinal Herniorrhaphy: Randomized Controlled Clinical Trial
Date of first enrolment: November 2014
Target sample size: 40
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT02299908
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Colombia
Contacts
Name:     Oscar D Aguirre Ospina, Specialist
Address: 
Telephone:
Email:
Affiliation:  Universidad de Caldas
Name:     Patricia Salazar Villegas, Mg.
Address: 
Telephone: (57) 6 8781500
Email: patricia.salazar@ucaldas.edu.co
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients over 18 years attending Servicios Especiales de Salud (SES) Hospital of
Caldas and Santa Sofia Hospital for inguinal hernia surgery.

- Physical status classification of the American Society of Anesthesiologists (ASA)
(ASA I: healthy patient with no history or comorbidity and ASA II patients with
compensated systemic disease).

- Acceptance to complete the informed consent.

Exclusion Criteria:

- Bilateral inguinal hernia.

- Allergy to drugs used in the study protocol (propofol, remifentanil, dipyrone,
Dexamethasone, Tramadol, Morphine, Bupivacaine, Cephalexin, Cefazolin, Lidocaine,
Sevoflurane, Chlorhexidine, Adrenaline, Naproxen, Acetaminophen)

- Lack of communication with the patient

- Inadequate social support network and interaction with the physician.

- Spinal Anesthesia

- Herniorrhaphy without mesh.

- Pregnancy

- Abuse of psychoactive substances.

- Daily consumption of opioids.

- Consumption of analgesics during the last 24 hours prior to surgery.

- Infection at the incision site



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pain, Postoperative
Intervention(s)
Drug: Placebo saline solution
Drug: TAP block with Bupivacaine at 0.25%
Primary Outcome(s)
Postoperative acute pain measured by the visual analog scale (VAS) from 1-10 with 1 being the lowest and 10 the highest intensity after one hour of anesthesia suspension. [Time Frame: 1 hour after the suspension of anesthesia]
Secondary Outcome(s)
Adverse reactions 1 [Time Frame: 1 hour after the suspension of anesthesia]
Opioid Consumption 1 [Time Frame: 1 hour after the suspension of anesthesia]
Adverse reactions 2 [Time Frame: 24 hours after the suspension of anesthesia]
Postoperative acute pain 2 [Time Frame: 24 hours after the suspension of anesthesia]
Opioid Consumption 2 [Time Frame: 24 hours after the suspension of anesthesia]
Secondary ID(s)
VIP 1691514
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history